News | February 14, 2023
NATCO files generic Olaparib Tablets in USA
Olaparib is indicated primarily for certain forms of ovarian, breast, pancreatic, and prostate cancer
Olaparib is indicated primarily for certain forms of ovarian, breast, pancreatic, and prostate cancer
DETAF would be a welcome new addition in the management of HIV infections and will be available for supplies to low- and middle-income countries
APF Futurity is made from polyolefin materials with no metal parts or recycling disruptors
Sacu V is priced at Rs. 19 per tablet for a dose of 50 mg (sacubitril 24 mg + valsartan 26 mg)
Dolutegravir and Rilpivirine Tablets, 50 mg/25 mg, (RLD Juluca) had estimated annual sales of US $666 million in the US (IQVIA MAT September 2022)
Brexpiprazole is an atypical antipsychotic indicated for use as an adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD) in adults
Febuxostat tablets had annual sales of USD 32 million in the United States according to IQVIA data (IQVIA MAT Sept. 2022).
Fesoterodine Fumarate Extended-Release Tablets, 4 mg and 8 mg, (RLD Toviaz®) had estimated annual sales of USD 177 million in the U.S. (IQVIA MAT September 2022).
Fesoterodine Fumarate Extended-Release Tablets, 4 mg and 8 mg, have an estimated market size of US$ 177 million for twelve months ending Sep 2022
Subscribe To Our Newsletter & Stay Updated
